Drug pipeline for worst superbugs "on life support": report

By Julie Steenhuysen CHICAGO (Reuters) – Only seven new drugs are in development for the treatment of infections caused by an especially nasty class of superbugs that include E. coli and CRE, the so-called “nightmare bacteria” that the U.S. Centers for Disease Control and Prevention raised alarms about last month. The data come from the latest report by the Infectious Diseases Society of America, or IDSA, released on Thursday, which has been tracking the rising number of bacteria that resist even the most potent antibiotics. …